Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
09 févr. 2024 10h45 HE
|
Ambu A/S
Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu...
GRANT OF PERFORMANCE SHARE UNITS
06 févr. 2024 08h41 HE
|
Ambu A/S
Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 172,956 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2023/24 have been granted on 6 February...
INTERIM REPORT FOR Q1 2023/24
30 janv. 2024 01h00 HE
|
Ambu A/S
In Q1 2023/24, Ambu delivered 14% organic revenue growth and a 10.0% EBIT margin before special items. This was driven by Endoscopy Solutions growing 25%, due to continued high double-digit growth...
ANNUAL REPORT 2022/23 (EARNINGS RELEASE)
08 nov. 2023 01h08 HE
|
Ambu A/S
For the full 2022/23 financial year, Ambu reported 7.6% organic revenue growth. This was driven by Endoscope Solutions posting 15% organic growth, the main drivers being urology and ENT growing high...
AMBU ANNOUNCES FINANCIAL OUTLOOK FOR THE 2023/24 FINANCIAL YEAR
08 nov. 2023 01h01 HE
|
Ambu A/S
Today, Ambu announces its financial guidance for the fiscal year 2023/24. Also, today, Ambu will publish its Q4 and full-year earnings release along with its Annual Report, including the company’s...
AMBU APPOINTS NEW CHIEF FINANCIAL OFFICER
11 oct. 2023 02h36 HE
|
Ambu A/S
Thomas Frederik Schmidt will step down as CFO of Ambu by 31 December 2023; Henrik Skak Bender named as new CFO, effective 1 January 2024. Ambu A/S has appointed Henrik Skak Bender as the...
AMBU ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE FISCAL YEAR 2022/23
09 oct. 2023 06h59 HE
|
Ambu A/S
Today, Ambu announces its preliminary financial 2022/23 results. For the financial year 2022/23, EBIT before special items totalled DKK 302m, with an EBIT margin before special items of 6.3% (previous...
AMBU FINANCIAL CALENDAR FOR 2023/24
29 sept. 2023 04h59 HE
|
Ambu A/S
This financial calendar lists the expected release dates of Ambu’s financial announcements for the financial year 2023/24, as well as the date of Ambu’s Annual General Meeting. 2023 8...
INTERIM REPORT FOR Q3 2022/23
31 août 2023 01h01 HE
|
Ambu A/S
In Q3 2022/23, Ambu delivered 8% organic revenue growth and a 7.6% EBIT margin. This was driven by Endoscopy Solutions growing 23%, due to high double-digit growth within urology and ENT, and...
Grant of Performance Share Units and reporting of transactions in accordance with Article 19 of the Market Abuse Regulation
28 juil. 2023 10h46 HE
|
Ambu A/S
Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 198,872 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2022/23 have been granted on 28 July...